The company conducted a randomised, double-blind, placebo-controlled study, including children with a genetic risk of developing gluten intolerance.
The results showed that Probi’s probiotics had a suppressing effect in coeliac auto-immunity, decreased the immunological responses to gluten intake and might delay the onset of gluten intolerance.
Probi has also continued to stack up clinical evidence for its Prob FerroSorb offer, which is designed to aid nutrient absorption.
“The iron absorption indication has been extended from a general female population to target groups such as pregnant women and athletes,” said Johan Wahlqvist, director of marketing and sales for consumer healthcare at Probi. “The addition of health-promoting probiotics, proven to survive the passage through the gastro-intestinal tract and with the ability to attach and colonise the intestine, will aid a more balanced gut microbiota.
“If I were a probiotic company operating in the EU, I would use the term. And if the EU objected, I would invite dialogue at comitology [the process by which EU law is modified or adjusted] until all member states are in agreement.”
- For more on digestive health issues, look out for p38-39 of Food Manufacture’s April issue, which comes out on 16 April.